R. Blomer

Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study.

G. Hommel, D. Haack, B. Krumme, 2003, American journal of hypertension.

A paediatric Crohn's disease activity index (PCDAI). Is it useful?

H. K. Harms, R. Bertele-Harms, M. König, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases.

C. Savopoulos, J. Husson, J. P. Young, 1980, The Journal of antimicrobial chemotherapy.

[Summarized results of clinical phase II and III studies with ofloxacin (HOE 280) in Europe].

R. Zahlten, K. Bruch, R. Blomer, 1986, Infection.

Ofloxacin in the treatment of gonococcal and chlamydial urethritis.

U. Klose, K. Bruch, R. Blomer, 1988, Clinical therapeutics.

The Influence of the Provider's Service Fairness on the Customer's Service Recovery Satisfaction and on Positive Behavioral Intentions in Cloud Computing

Montri Lawkobkit, Roland Blomer, M. Lawkobkit, 2015, CLOSER.

Safety of ofloxacin — adverse drug reactions reported during phase-II studies in europe and in Japan

K. Bruch, R. Blomer, H. Krauss, 2005, Infection.

The status of IT service management in health care - ITIL® in selected European countries

Alexander Hörbst, Elske Ammenwerth, Roland Blomer, 2011, BMC Medical Informatics Decis. Mak..